Navigate Regulatory, Supply & Operational Hurdles to Streamline Patient Access, Optimise Compliant Real-World Evidence, & Deliver Scalable EAPs for Chronic & Rare Diseases
When patients can’t afford to wait, Early Access Programmes become a vital lifeline. With growing demand across rare diseases, oncology, and advanced therapies, and rising expectations from regulators, physicians, and patients, the need to execute programmes effectively has never been greater. Access teams face complex regulatory environments worldwide, limited internal resources, and increased scrutiny on compliance, data, and supply.
At the 4th Operationalise: Early Access Programmes Summit Europe, you’ll hear from 120+ leaders across Access, Clinical Operations, Medical Affairs, Regulatory, and Supply Chain, sharing real-world case studies from global regions and markets. This is your opportunity to learn proven strategies and frameworks that you can directly apply to your own programmes, whether you’re launching your first early access initiative or managing a complex, multi-country portfolio.
Join us to gain practical insights and peer-led solutions that will empower you to navigate the evolving global landscape with confidence and precision.
2025 Expert Speakers Included:
Attending Companies Included